{
  "metadata": {
    "id": "U4AOS2-16-EnzymeInhibitors",
    "curriculum": "VCEAU",
    "subject": "chemistry",
    "dotPoint": "Competitive enzyme inhibitors and the lock-and-key mechanism",
    "colorTheme": {
      "primary": "#a855f7",
      "secondary": "#7c3aed"
    }
  },
  "tabs": [
    {
      "id": "lock-and-key",
      "label": "Lock and Key",
      "icon": "key",
      "order": 1
    },
    {
      "id": "competitive-inhibition",
      "label": "Competitive Inhibition",
      "icon": "ban",
      "order": 2
    },
    {
      "id": "drug-applications",
      "label": "Drug Applications",
      "icon": "pills",
      "order": 3
    }
  ],
  "concepts": {
    "lock-and-key": {
      "name": "Lock-and-Key Model",
      "formula": null,
      "correct": "The lock-and-key model proposes that substrate fits precisely into the enzyme's active site like a key in a lock",
      "wrong": {
        "enzyme changes shape completely": {
          "error": "Describing induced fit, not lock-and-key",
          "fix": "Lock-and-key assumes rigid, pre-formed complementary shapes",
          "action": "Lock-and-key: rigid; induced fit: flexible"
        },
        "any substrate can fit any enzyme": {
          "error": "Missing specificity principle",
          "fix": "Only substrates with correct shape fit the active site",
          "action": "Shape complementarity provides enzyme specificity"
        },
        "the lock is the substrate": {
          "error": "Reversing the analogy",
          "fix": "Enzyme is the lock (fixed); substrate is the key (fits into it)",
          "action": "Enzyme active site = lock; substrate = key"
        }
      },
      "persistent": {
        "gap": "Not understanding lock-and-key as shape complementarity",
        "action": "Active site shape precisely matches substrate shape"
      }
    },
    "enzyme-substrate-complex": {
      "name": "Enzyme-Substrate Complex",
      "formula": "E + S ⇌ ES → E + P",
      "correct": "Substrate binds to active site forming enzyme-substrate complex, then products are released",
      "wrong": {
        "enzyme is permanently changed": {
          "error": "Missing enzyme regeneration",
          "fix": "Enzyme is released unchanged and can catalyse more reactions",
          "action": "E + S → ES → E + P; enzyme recycled"
        },
        "binding is irreversible": {
          "error": "Missing equilibrium nature",
          "fix": "ES formation is reversible; substrate can dissociate without reacting",
          "action": "Equilibrium between E + S and ES"
        },
        "products stay bound": {
          "error": "Products must leave for turnover",
          "fix": "Products have different shape and leave the active site",
          "action": "Product release allows next substrate to bind"
        }
      },
      "persistent": {
        "gap": "Not understanding the catalytic cycle",
        "action": "Enzyme binds substrate, catalyses reaction, releases product, repeats"
      }
    },
    "competitive-inhibition": {
      "name": "Competitive Inhibition",
      "formula": null,
      "correct": "Competitive inhibitors bind to the active site, competing with substrate for the same binding location",
      "wrong": {
        "binds elsewhere on enzyme": {
          "error": "Describing non-competitive inhibition",
          "fix": "Competitive inhibitors bind AT the active site, blocking substrate",
          "action": "Competitive = active site; non-competitive = different site"
        },
        "permanently destroys enzyme": {
          "error": "Competitive inhibition is reversible",
          "fix": "Inhibitor binding is reversible; high substrate can overcome it",
          "action": "More substrate can outcompete the inhibitor"
        },
        "has completely different shape from substrate": {
          "error": "Missing structural similarity requirement",
          "fix": "Competitive inhibitors have similar shape to substrate to fit active site",
          "action": "Inhibitor mimics substrate shape"
        }
      },
      "persistent": {
        "gap": "Not understanding competitive inhibition mechanism",
        "action": "Similar-shaped inhibitor blocks substrate from active site"
      }
    },
    "inhibitor-structure": {
      "name": "Inhibitor Structure",
      "formula": null,
      "correct": "Competitive inhibitors structurally resemble the substrate to fit the active site",
      "wrong": {
        "any molecule can inhibit": {
          "error": "Missing structural requirement",
          "fix": "Only molecules with complementary shape to active site can bind",
          "action": "Inhibitor must fit the lock just like the substrate key"
        },
        "larger molecules are better inhibitors": {
          "error": "Size isn't the determining factor",
          "fix": "Shape complementarity matters most; size must match active site",
          "action": "Must fit active site, not just be large"
        },
        "inhibitors are always synthetic": {
          "error": "Missing natural inhibitors",
          "fix": "Many competitive inhibitors are natural products or derived from them",
          "action": "Both natural and synthetic competitive inhibitors exist"
        }
      },
      "persistent": {
        "gap": "Not connecting inhibitor structure to mechanism",
        "action": "Structural similarity to substrate allows active site binding"
      }
    },
    "reversibility": {
      "name": "Reversibility of Inhibition",
      "formula": null,
      "correct": "Competitive inhibition is reversible; increasing substrate concentration can overcome inhibition",
      "wrong": {
        "inhibition is always permanent": {
          "error": "Missing reversibility",
          "fix": "Competitive inhibitors bind reversibly via non-covalent interactions",
          "action": "Inhibitor can unbind; substrate can then bind"
        },
        "more inhibitor always wins": {
          "error": "Missing substrate competition",
          "fix": "High substrate concentration can outcompete inhibitor for active sites",
          "action": "It's a competition: more substrate = less inhibition"
        },
        "maximum velocity cannot be reached": {
          "error": "Incorrect effect on Vmax",
          "fix": "With enough substrate, Vmax can be reached despite inhibitor",
          "action": "Competitive inhibition increases Km but doesn't change Vmax"
        }
      },
      "persistent": {
        "gap": "Not understanding competitive inhibition reversibility",
        "action": "Substrate and inhibitor compete; excess substrate overcomes inhibition"
      }
    },
    "drug-design": {
      "name": "Drug Design",
      "formula": null,
      "correct": "Many drugs work as competitive enzyme inhibitors, blocking enzymes involved in disease",
      "wrong": {
        "all drugs are enzyme inhibitors": {
          "error": "Overgeneralising mechanism",
          "fix": "Many drugs work by other mechanisms (receptor binding, etc.)",
          "action": "Enzyme inhibition is one important drug mechanism among many"
        },
        "inhibiting any enzyme is therapeutic": {
          "error": "Missing target selectivity",
          "fix": "Drug must inhibit specific disease-related enzyme without affecting others",
          "action": "Selectivity is crucial to avoid side effects"
        },
        "drugs bind permanently": {
          "error": "Most competitive drugs bind reversibly",
          "fix": "Reversible binding allows dose adjustment and cessation",
          "action": "Reversible inhibitors allow controlled therapy"
        }
      },
      "persistent": {
        "gap": "Not connecting enzyme inhibition to drug action",
        "action": "Drugs can block disease-related enzymes by competitive inhibition"
      }
    },
    "examples": {
      "name": "Inhibitor Examples",
      "formula": null,
      "correct": "Statins inhibit cholesterol synthesis enzyme; many antibiotics inhibit bacterial enzymes",
      "wrong": {
        "only one class of drugs uses inhibition": {
          "error": "Missing diversity of inhibitor drugs",
          "fix": "Many drug classes use enzyme inhibition: statins, antibiotics, antivirals, etc.",
          "action": "Enzyme inhibition is widespread in pharmacology"
        },
        "inhibitors are toxic": {
          "error": "Confusing inhibition with toxicity",
          "fix": "Selective inhibition of disease-related enzymes is therapeutic, not toxic",
          "action": "Correct target = medicine; wrong target = poison"
        },
        "examples are only synthetic": {
          "error": "Missing natural inhibitors",
          "fix": "Penicillin (natural antibiotic) is a competitive enzyme inhibitor",
          "action": "Natural and synthetic enzyme inhibitors both used as drugs"
        }
      },
      "persistent": {
        "gap": "Not knowing examples of enzyme inhibitor drugs",
        "action": "Learn: statins (HMG-CoA reductase), antibiotics (transpeptidase)"
      }
    },
    "selectivity": {
      "name": "Enzyme Selectivity",
      "formula": null,
      "correct": "Effective drugs selectively inhibit target enzymes without affecting similar enzymes elsewhere",
      "wrong": {
        "selectivity doesn't matter": {
          "error": "Missing importance of selectivity",
          "fix": "Non-selective inhibitors cause side effects by affecting non-target enzymes",
          "action": "Selectivity = efficacy with minimal side effects"
        },
        "all enzymes are equally affected": {
          "error": "Missing enzyme diversity",
          "fix": "Active sites differ; inhibitor binds best to target enzyme",
          "action": "Design inhibitors to fit target but not similar enzymes"
        },
        "perfect selectivity is easy": {
          "error": "Underestimating challenge",
          "fix": "Achieving high selectivity is a major drug design challenge",
          "action": "Related enzymes may have similar active sites"
        }
      },
      "persistent": {
        "gap": "Not understanding selectivity importance in drug design",
        "action": "Good drug: high target inhibition, low off-target effects"
      }
    }
  },
  "content": {
    "round1": {
      "lock-and-key": {
        "sentences": [
          {
            "text": "The lock-and-key model compares the enzyme's {{d1}} site to a lock and the {{d2}} to a key.",
            "questions": {
              "d1": {
                "correct": "active",
                "distractors": [
                  "binding",
                  "allosteric",
                  "catalytic"
                ],
                "concept": "lock-and-key",
                "tooltip": "Active site is the 'lock'"
              },
              "d2": {
                "correct": "substrate",
                "distractors": [
                  "product",
                  "enzyme",
                  "inhibitor"
                ],
                "concept": "lock-and-key",
                "tooltip": "Substrate is the 'key'"
              }
            }
          },
          {
            "text": "In this model, the substrate has a {{d1}} shape that fits precisely into the {{d2}} shape of the active site.",
            "questions": {
              "d1": {
                "correct": "complementary",
                "distractors": [
                  "identical",
                  "opposite",
                  "random"
                ],
                "concept": "lock-and-key",
                "tooltip": "Shapes are complementary, not identical"
              },
              "d2": {
                "correct": "fixed",
                "distractors": [
                  "changing",
                  "flexible",
                  "variable"
                ],
                "concept": "lock-and-key",
                "tooltip": "Lock-and-key assumes rigid active site"
              }
            }
          },
          {
            "text": "When substrate binds to enzyme, an {{d1}}-{{d2}} complex forms. This then breaks down to release {{d3}} and regenerate the enzyme.",
            "questions": {
              "d1": {
                "correct": "enzyme",
                "distractors": [
                  "inhibitor",
                  "product",
                  "water"
                ],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Enzyme part of the complex"
              },
              "d2": {
                "correct": "substrate",
                "distractors": [
                  "product",
                  "water",
                  "ion"
                ],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Substrate binds to form ES complex"
              },
              "d3": {
                "correct": "products",
                "distractors": [
                  "substrates",
                  "enzymes",
                  "inhibitors"
                ],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Products are released after reaction"
              }
            }
          }
        ]
      },
      "competitive-inhibition": {
        "sentences": [
          {
            "text": "A competitive inhibitor has a similar {{d1}} to the substrate and binds to the {{d2}} site.",
            "questions": {
              "d1": {
                "correct": "shape",
                "distractors": [
                  "colour",
                  "mass",
                  "charge only"
                ],
                "concept": "inhibitor-structure",
                "tooltip": "Structural similarity is key"
              },
              "d2": {
                "correct": "active",
                "distractors": [
                  "allosteric",
                  "different",
                  "random"
                ],
                "concept": "competitive-inhibition",
                "tooltip": "Competitive inhibitors bind AT active site"
              }
            }
          },
          {
            "text": "When the inhibitor occupies the active site, the {{d1}} cannot bind, so the {{d2}} is slowed.",
            "questions": {
              "d1": {
                "correct": "substrate",
                "distractors": [
                  "product",
                  "enzyme",
                  "water"
                ],
                "concept": "competitive-inhibition",
                "tooltip": "Inhibitor blocks substrate binding"
              },
              "d2": {
                "correct": "reaction",
                "distractors": [
                  "colour change",
                  "mass",
                  "volume"
                ],
                "concept": "competitive-inhibition",
                "tooltip": "Less substrate binding = slower reaction"
              }
            }
          },
          {
            "text": "Competitive inhibition is {{d1}} because increasing {{d2}} concentration can overcome the inhibition.",
            "questions": {
              "d1": {
                "correct": "reversible",
                "distractors": [
                  "irreversible",
                  "permanent",
                  "fixed"
                ],
                "concept": "reversibility",
                "tooltip": "Inhibitor can be displaced"
              },
              "d2": {
                "correct": "substrate",
                "distractors": [
                  "inhibitor",
                  "enzyme",
                  "product"
                ],
                "concept": "reversibility",
                "tooltip": "More substrate outcompetes inhibitor"
              }
            }
          }
        ]
      },
      "drug-applications": {
        "sentences": [
          {
            "text": "Many drugs work as {{d1}} enzyme inhibitors, blocking enzymes involved in {{d2}}.",
            "questions": {
              "d1": {
                "correct": "competitive",
                "distractors": [
                  "random",
                  "destructive",
                  "enhancing"
                ],
                "concept": "drug-design",
                "tooltip": "Drugs often competitively inhibit enzymes"
              },
              "d2": {
                "correct": "disease",
                "distractors": [
                  "health",
                  "growth",
                  "nutrition"
                ],
                "concept": "drug-design",
                "tooltip": "Target enzymes are disease-related"
              }
            }
          },
          {
            "text": "Effective enzyme inhibitor drugs must be {{d1}}, affecting the target enzyme without inhibiting {{d2}} enzymes.",
            "questions": {
              "d1": {
                "correct": "selective",
                "distractors": [
                  "random",
                  "universal",
                  "destructive"
                ],
                "concept": "selectivity",
                "tooltip": "Selectivity minimises side effects"
              },
              "d2": {
                "correct": "other",
                "distractors": [
                  "the same",
                  "no",
                  "all"
                ],
                "concept": "selectivity",
                "tooltip": "Avoid off-target effects"
              }
            }
          },
          {
            "text": "Statins are competitive inhibitors of HMG-CoA {{d1}}, an enzyme involved in {{d2}} synthesis.",
            "questions": {
              "d1": {
                "correct": "reductase",
                "distractors": [
                  "synthase",
                  "kinase",
                  "phosphatase"
                ],
                "concept": "examples",
                "tooltip": "HMG-CoA reductase is the target"
              },
              "d2": {
                "correct": "cholesterol",
                "distractors": [
                  "protein",
                  "DNA",
                  "glucose"
                ],
                "concept": "examples",
                "tooltip": "Statins lower cholesterol"
              }
            }
          }
        ]
      }
    },
    "round2": {
      "lock-and-key": {
        "sentences": [
          {
            "text": "The lock-and-key model explains enzyme {{d1}}: only substrates with the correct {{d2}} can fit the active site. A different substrate is like a wrong {{d3}} that doesn't fit the lock.",
            "questions": {
              "d1": {
                "correct": "specificity",
                "distractors": [
                  "colour",
                  "mass",
                  "charge"
                ],
                "concept": "lock-and-key",
                "tooltip": "Shape matching provides specificity"
              },
              "d2": {
                "correct": "shape",
                "distractors": [
                  "colour",
                  "mass",
                  "charge"
                ],
                "concept": "lock-and-key",
                "tooltip": "Shape complementarity is essential"
              },
              "d3": {
                "correct": "key",
                "distractors": [
                  "lock",
                  "door",
                  "handle"
                ],
                "concept": "lock-and-key",
                "tooltip": "Wrong key won't fit the lock"
              }
            }
          },
          {
            "text": "The enzyme-substrate complex is held together by {{d1}} interactions between the substrate and amino acids in the {{d2}} site. These include hydrogen bonds, ionic interactions, and {{d3}} forces.",
            "questions": {
              "d1": {
                "correct": "non-covalent",
                "distractors": [
                  "covalent only",
                  "metallic",
                  "nuclear"
                ],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Non-covalent = reversible binding"
              },
              "d2": {
                "correct": "active",
                "distractors": [
                  "passive",
                  "random",
                  "external"
                ],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Binding occurs at active site"
              },
              "d3": {
                "correct": "hydrophobic",
                "distractors": [
                  "magnetic",
                  "gravitational",
                  "nuclear"
                ],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Non-polar regions interact"
              }
            }
          }
        ]
      },
      "competitive-inhibition": {
        "sentences": [
          {
            "text": "A competitive inhibitor resembles the {{d1}} closely enough to fit the active site, but unlike the substrate, it doesn't undergo the {{d2}} reaction. It just {{d3}} the site.",
            "questions": {
              "d1": {
                "correct": "substrate",
                "distractors": [
                  "product",
                  "enzyme",
                  "water"
                ],
                "concept": "inhibitor-structure",
                "tooltip": "Inhibitor mimics substrate shape"
              },
              "d2": {
                "correct": "catalytic",
                "distractors": [
                  "binding",
                  "folding",
                  "dissolving"
                ],
                "concept": "competitive-inhibition",
                "tooltip": "Inhibitor is not converted to product"
              },
              "d3": {
                "correct": "blocks",
                "distractors": [
                  "destroys",
                  "expands",
                  "creates"
                ],
                "concept": "competitive-inhibition",
                "tooltip": "Inhibitor occupies the site"
              }
            }
          },
          {
            "text": "With competitive inhibition, {{d1}} substrate concentration can restore enzyme activity because substrate molecules can {{d2}} inhibitor molecules for active site {{d3}}.",
            "questions": {
              "d1": {
                "correct": "high",
                "distractors": [
                  "low",
                  "zero",
                  "negative"
                ],
                "concept": "reversibility",
                "tooltip": "Excess substrate overcomes inhibition"
              },
              "d2": {
                "correct": "outcompete",
                "distractors": [
                  "join",
                  "destroy",
                  "enhance"
                ],
                "concept": "reversibility",
                "tooltip": "Numbers game: more substrate = more binding"
              },
              "d3": {
                "correct": "binding",
                "distractors": [
                  "colour",
                  "mass",
                  "charge"
                ],
                "concept": "reversibility",
                "tooltip": "They compete for same binding site"
              }
            }
          },
          {
            "text": "The effect of competitive inhibition on enzyme kinetics: the apparent {{d1}} increases (harder to saturate enzyme), but maximum {{d2}} remains unchanged (at high substrate, inhibition is overcome).",
            "questions": {
              "d1": {
                "correct": "Km",
                "distractors": [
                  "Vmax",
                  "pH",
                  "temperature"
                ],
                "concept": "reversibility",
                "tooltip": "Km increases with competitive inhibitor"
              },
              "d2": {
                "correct": "velocity",
                "distractors": [
                  "mass",
                  "colour",
                  "charge"
                ],
                "concept": "reversibility",
                "tooltip": "Vmax unchanged; just need more substrate"
              }
            }
          }
        ]
      },
      "drug-applications": {
        "sentences": [
          {
            "text": "Penicillin is a competitive inhibitor of the bacterial enzyme {{d1}}. This enzyme is essential for building bacterial cell {{d2}}. Without it, bacteria cannot {{d3}}.",
            "questions": {
              "d1": {
                "correct": "transpeptidase",
                "distractors": [
                  "DNA polymerase",
                  "ATP synthase",
                  "ribosome"
                ],
                "concept": "examples",
                "tooltip": "Transpeptidase builds cell wall"
              },
              "d2": {
                "correct": "walls",
                "distractors": [
                  "membranes",
                  "DNA",
                  "ribosomes"
                ],
                "concept": "examples",
                "tooltip": "Cell wall synthesis is blocked"
              },
              "d3": {
                "correct": "survive and reproduce",
                "distractors": [
                  "photosynthesize",
                  "digest",
                  "think"
                ],
                "concept": "examples",
                "tooltip": "Wall-less bacteria die"
              }
            }
          },
          {
            "text": "Drug designers analyse the {{d1}} of the target enzyme's active site. They then design molecules with complementary {{d2}} that will bind tightly but not be processed as {{d3}}.",
            "questions": {
              "d1": {
                "correct": "structure",
                "distractors": [
                  "colour",
                  "smell",
                  "taste"
                ],
                "concept": "drug-design",
                "tooltip": "Know the active site structure"
              },
              "d2": {
                "correct": "shape",
                "distractors": [
                  "colour",
                  "smell",
                  "taste"
                ],
                "concept": "drug-design",
                "tooltip": "Design shape to fit active site"
              },
              "d3": {
                "correct": "substrates",
                "distractors": [
                  "enzymes",
                  "products",
                  "inhibitors"
                ],
                "concept": "drug-design",
                "tooltip": "Inhibitor doesn't react"
              }
            }
          },
          {
            "text": "Selectivity challenges: human and bacterial enzymes may have {{d1}} active sites. An antibiotic must bind bacterial enzyme but not the {{d2}} human equivalent.",
            "questions": {
              "d1": {
                "correct": "similar",
                "distractors": [
                  "identical",
                  "opposite",
                  "unrelated"
                ],
                "concept": "selectivity",
                "tooltip": "Evolved from common ancestors"
              },
              "d2": {
                "correct": "similar",
                "distractors": [
                  "different",
                  "larger",
                  "smaller"
                ],
                "concept": "selectivity",
                "tooltip": "Must discriminate between similar enzymes"
              }
            }
          }
        ]
      }
    },
    "round3": {
      "lock-and-key": {
        "sentences": [
          {
            "text": "The lock-and-key model was proposed by Emil Fischer. While useful, it has been refined by the {{d1}} fit model, which recognises that active sites can undergo {{d2}} changes upon substrate binding. Both models emphasise {{d3}} complementarity.",
            "questions": {
              "d1": {
                "correct": "induced",
                "distractors": [
                  "forced",
                  "random",
                  "permanent"
                ],
                "concept": "lock-and-key",
                "tooltip": "Induced fit allows flexibility"
              },
              "d2": {
                "correct": "conformational",
                "distractors": [
                  "colour",
                  "mass",
                  "charge"
                ],
                "concept": "lock-and-key",
                "tooltip": "Shape can adjust slightly"
              },
              "d3": {
                "correct": "shape",
                "distractors": [
                  "colour",
                  "mass",
                  "charge"
                ],
                "concept": "lock-and-key",
                "tooltip": "Shape matching remains central"
              }
            }
          },
          {
            "text": "When the enzyme-substrate complex forms, the substrate is held in the optimal {{d1}} for the reaction. Functional groups in the active site may participate in {{d2}}. After reaction, products have {{d3}} shape and leave the active site.",
            "questions": {
              "d1": {
                "correct": "orientation",
                "distractors": [
                  "colour",
                  "mass",
                  "charge"
                ],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Correct positioning is essential"
              },
              "d2": {
                "correct": "catalysis",
                "distractors": [
                  "inhibition",
                  "denaturation",
                  "folding"
                ],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Active site residues assist reaction"
              },
              "d3": {
                "correct": "different",
                "distractors": [
                  "identical",
                  "same",
                  "complementary"
                ],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Products don't fit well, so they leave"
              }
            }
          }
        ]
      },
      "competitive-inhibition": {
        "sentences": [
          {
            "text": "Comparing substrate and competitive inhibitor: both have {{d1}} shapes that fit the active site. The substrate is converted to {{d2}}; the inhibitor is {{d3}}. This means inhibitor occupies the site without productive reaction.",
            "questions": {
              "d1": {
                "correct": "similar",
                "distractors": [
                  "identical",
                  "different",
                  "opposite"
                ],
                "concept": "inhibitor-structure",
                "tooltip": "Similar but not identical shapes"
              },
              "d2": {
                "correct": "products",
                "distractors": [
                  "inhibitors",
                  "enzymes",
                  "substrates"
                ],
                "concept": "competitive-inhibition",
                "tooltip": "Substrate undergoes catalysis"
              },
              "d3": {
                "correct": "not converted",
                "distractors": [
                  "converted",
                  "destroyed",
                  "multiplied"
                ],
                "concept": "competitive-inhibition",
                "tooltip": "Inhibitor just occupies site"
              }
            }
          },
          {
            "text": "Methotrexate is a competitive inhibitor of dihydrofolate {{d1}}, an enzyme essential for {{d2}} synthesis. Cancer cells need rapid DNA synthesis, so inhibiting this enzyme slows {{d3}} growth.",
            "questions": {
              "d1": {
                "correct": "reductase",
                "distractors": [
                  "synthase",
                  "kinase",
                  "phosphatase"
                ],
                "concept": "examples",
                "tooltip": "DHFR is the target enzyme"
              },
              "d2": {
                "correct": "DNA",
                "distractors": [
                  "fat",
                  "carbohydrate",
                  "water"
                ],
                "concept": "examples",
                "tooltip": "Folate needed for nucleotide synthesis"
              },
              "d3": {
                "correct": "tumour",
                "distractors": [
                  "normal",
                  "healthy",
                  "nerve"
                ],
                "concept": "examples",
                "tooltip": "Anticancer drug targets rapid division"
              }
            }
          }
        ]
      },
      "drug-applications": {
        "sentences": [
          {
            "text": "The drug design process for competitive inhibitors: (1) identify disease-related {{d1}}, (2) determine active site {{d2}}, (3) design molecules that fit the site but aren't {{d3}}, (4) test for {{d4}} (binding target vs others).",
            "questions": {
              "d1": {
                "correct": "enzyme",
                "distractors": [
                  "colour",
                  "smell",
                  "taste"
                ],
                "concept": "drug-design",
                "tooltip": "Find the enzyme to target"
              },
              "d2": {
                "correct": "structure",
                "distractors": [
                  "colour",
                  "smell",
                  "taste"
                ],
                "concept": "drug-design",
                "tooltip": "Know the active site in detail"
              },
              "d3": {
                "correct": "substrates",
                "distractors": [
                  "inhibitors",
                  "drugs",
                  "proteins"
                ],
                "concept": "drug-design",
                "tooltip": "Don't want it to react"
              },
              "d4": {
                "correct": "selectivity",
                "distractors": [
                  "colour",
                  "smell",
                  "taste"
                ],
                "concept": "selectivity",
                "tooltip": "Must only affect target"
              }
            }
          },
          {
            "text": "HIV protease inhibitors are competitive inhibitors that block viral {{d1}} processing. They resemble the natural {{d2}} sequence that the protease normally cleaves. By blocking this enzyme, new virus particles cannot {{d3}}.",
            "questions": {
              "d1": {
                "correct": "protein",
                "distractors": [
                  "fat",
                  "carbohydrate",
                  "water"
                ],
                "concept": "examples",
                "tooltip": "HIV protease processes viral proteins"
              },
              "d2": {
                "correct": "peptide",
                "distractors": [
                  "lipid",
                  "sugar",
                  "nucleotide"
                ],
                "concept": "inhibitor-structure",
                "tooltip": "Inhibitors mimic peptide substrates"
              },
              "d3": {
                "correct": "mature",
                "distractors": [
                  "infect",
                  "reproduce",
                  "survive"
                ],
                "concept": "examples",
                "tooltip": "Immature virus particles are non-infectious"
              }
            }
          }
        ]
      }
    }
  },
  "explanations": {
    "lock-and-key": "The lock-and-key model proposes rigid complementary shapes between enzyme active site (lock) and substrate (key).",
    "enzyme-substrate-complex": "Substrate binds to active site forming ES complex, then products are released and enzyme is recycled.",
    "competitive-inhibition": "Competitive inhibitors bind to active site, blocking substrate; similar shape to substrate required.",
    "inhibitor-structure": "Competitive inhibitors structurally resemble substrates to fit and block the active site.",
    "reversibility": "Competitive inhibition is reversible; high substrate concentration can outcompete inhibitor.",
    "drug-design": "Many drugs work as selective competitive enzyme inhibitors targeting disease-related enzymes.",
    "examples": "Statins (cholesterol), antibiotics (bacterial wall), antivirals (viral processing) use competitive inhibition.",
    "selectivity": "Effective drugs selectively inhibit target enzymes without affecting similar enzymes, minimising side effects."
  }
}